Literature DB >> 23975452

Genotype-phenotype correlations in neurogenetics: Lesch-Nyhan disease as a model disorder.

Rong Fu1, Irene Ceballos-Picot, Rosa J Torres, Laura E Larovere, Yasukazu Yamada, Khue V Nguyen, Madhuri Hegde, Jasper E Visser, David J Schretlen, William L Nyhan, Juan G Puig, Patrick J O'Neill, H A Jinnah.   

Abstract

Establishing meaningful relationships between genetic variations and clinical disease is a fundamental goal for all human genetic disorders. However, these genotype-phenotype correlations remain incompletely characterized and sometimes conflicting for many diseases. Lesch-Nyhan disease is an X-linked recessive disorder that is caused by a wide variety of mutations in the HPRT1 gene. The gene encodes hypoxanthine-guanine phosphoribosyl transferase, an enzyme involved in purine metabolism. The fine structure of enzyme has been established by crystallography studies, and its function can be measured with very precise biochemical assays. This rich knowledge of genetic alterations in the gene and their functional effect on its protein product provides a powerful model for exploring factors that influence genotype-phenotype correlations. The present study summarizes 615 known genetic mutations, their influence on the gene product, and their relationship to the clinical phenotype. In general, the results are compatible with the concept that the overall severity of the disease depends on how mutations ultimately influence enzyme activity. However, careful evaluation of exceptions to this concept point to several additional genetic and non-genetic factors that influence genotype-phenotype correlations. These factors are not unique to Lesch-Nyhan disease, and are relevant to most other genetic diseases. The disease therefore serves as a valuable model for understanding the challenges associated with establishing genotype-phenotype correlations for other disorders.

Entities:  

Keywords:  Lesch-Nyhan disease; genotype–phenotype correlations; neurogenetics

Mesh:

Substances:

Year:  2013        PMID: 23975452      PMCID: PMC3999711          DOI: 10.1093/brain/awt202

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  168 in total

1.  Molecular analysis of hypoxanthine-guanine phosphoribosyltransferase deficiency in Japanese patients.

Authors:  S Fujimori; T Tagaya; N Yamaoka; N Kamatani; I Akaoka
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

2.  The crystal structure of free human hypoxanthine-guanine phosphoribosyltransferase reveals extensive conformational plasticity throughout the catalytic cycle.

Authors:  Dianne T Keough; Ian M Brereton; John de Jersey; Luke W Guddat
Journal:  J Mol Biol       Date:  2005-08-05       Impact factor: 5.469

3.  Hypoxanthine guanine phosphoribosyltransferase (HPRT) mutations in the Asian population.

Authors:  Y Yamada; N Wakamatsu; A Taniguchi; K Kaneko; S Fujimori
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2011-12       Impact factor: 1.381

Review 4.  Update on the phenotypic spectrum of Lesch-Nyhan disease and its attenuated variants.

Authors:  Rosa J Torres; Juan G Puig; H A Jinnah
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

Review 5.  The spectrum of inherited mutations causing HPRT deficiency: 75 new cases and a review of 196 previously reported cases.

Authors:  H A Jinnah; L De Gregorio; J C Harris; W L Nyhan; J P O'Neill
Journal:  Mutat Res       Date:  2000-10       Impact factor: 2.433

6.  Partial hypoxanthine-Guanine phosphoribosyltransferase deficiency as the unsuspected cause of renal disease spanning three generations: a cautionary tale.

Authors:  Persephone Augoustides-Savvopoulou; Fotis Papachristou; Lynette D Fairbanks; Kostas Dimitrakopoulos; Anthony M Marinaki; H Anne Simmonds
Journal:  Pediatrics       Date:  2002-01       Impact factor: 7.124

7.  A female case of the Leach-Nyhan syndrome.

Authors:  K Hara; S Kashiwamata; N Ogasawara; H Ohishi; R Natsume; T Yamanaka; S Hakamada; S Miyazaki; K Watanabe
Journal:  Tohoku J Exp Med       Date:  1982-07       Impact factor: 1.848

8.  Differential diagnosis of cerebral palsy: Lesch-Nyhan syndrome without self-mutilation.

Authors:  G Mitchell; R R McInnes
Journal:  Can Med Assoc J       Date:  1984-05-15       Impact factor: 8.262

9.  Levodopa therapy in a Lesch-Nyhan disease patient: pathological, biochemical, neuroimaging, and therapeutic remarks.

Authors:  Mercedes Serrano; Belen Pérez-Dueñas; Aida Ormazábal; Rafael Artuch; Jaume Campistol; Rosa J Torres; Angels García-Cazorla
Journal:  Mov Disord       Date:  2008-07-15       Impact factor: 10.338

10.  Variable expression of HPRT deficiency in 5 members of a family with the same mutation.

Authors:  Uros Hladnik; William L Nyhan; Matteo Bertelli
Journal:  Arch Neurol       Date:  2008-09
View more
  39 in total

Review 1.  Cystinuria: genetic aspects, mouse models, and a new approach to therapy.

Authors:  Amrik Sahota; Jay A Tischfield; David S Goldfarb; Michael D Ward; Longqin Hu
Journal:  Urolithiasis       Date:  2018-12-04       Impact factor: 3.436

2.  Mild Lesch-Nyhan Disease in a Boy with a Null Mutation in HPRT1: An Exception to the Known Genotype-Phenotype Correlation.

Authors:  Allan Bayat; Mette Christensen; Flemming Wibrand; Morten Duno; Allan Lund
Journal:  JIMD Rep       Date:  2014-11-04

3.  CRISPR/Cas9-Mediated Scanning for Regulatory Elements Required for HPRT1 Expression via Thousands of Large, Programmed Genomic Deletions.

Authors:  Molly Gasperini; Gregory M Findlay; Aaron McKenna; Jennifer H Milbank; Choli Lee; Melissa D Zhang; Darren A Cusanovich; Jay Shendure
Journal:  Am J Hum Genet       Date:  2017-07-14       Impact factor: 11.025

4.  Regional brain volume abnormalities in Lesch-Nyhan disease and its variants: a cross-sectional study.

Authors:  David J Schretlen; Mark Varvaris; Tiffany E Ho; Tracy D Vannorsdall; Barry Gordon; James C Harris; H A Jinnah
Journal:  Lancet Neurol       Date:  2013-12       Impact factor: 44.182

5.  Altered gastrointestinal motility in an animal model of Lesch-Nyhan disease.

Authors:  Maria G Zizzo; Monica Frinchi; Domenico Nuzzo; Hyder A Jinnah; Giuseppa Mudò; Daniele F Condorelli; Francesco Caciagli; Renata Ciccarelli; Patrizia Di Iorio; Flavia Mulè; Natale Belluardo; Rosa Serio
Journal:  Auton Neurosci       Date:  2017-12-20       Impact factor: 3.145

6.  Purinosome formation as a function of the cell cycle.

Authors:  Chung Yu Chan; Hong Zhao; Raymond J Pugh; Anthony M Pedley; Jarrod French; Sara A Jones; Xiaowei Zhuang; Hyder Jinnah; Tony Jun Huang; Stephen J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

7.  Do clinical features of Lesch-Nyhan disease correlate more closely with hypoxanthine or guanine recycling?

Authors:  David J Schretlen; Wynne Callon; Rebecca E Ward; Rong Fu; Tiffany Ho; Barry Gordon; James C Harris; H A Jinnah
Journal:  J Inherit Metab Dis       Date:  2015-06-12       Impact factor: 4.982

8.  Clinical severity in Lesch-Nyhan disease: the role of residual enzyme and compensatory pathways.

Authors:  Rong Fu; Diane Sutcliffe; Hong Zhao; Xinyi Huang; David J Schretlen; Steve Benkovic; H A Jinnah
Journal:  Mol Genet Metab       Date:  2014-11-08       Impact factor: 4.797

Review 9.  Genotypic and phenotypic spectrum in attenuated variants of Lesch-Nyhan disease.

Authors:  Rong Fu; Chung-Jen Chen; H A Jinnah
Journal:  Mol Genet Metab       Date:  2014-05-28       Impact factor: 4.797

10.  Skewed X inactivation in Lesch-Nyhan disease carrier females.

Authors:  Rosa J Torres; Juan G Puig
Journal:  J Hum Genet       Date:  2017-09-14       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.